These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5985458)

  • 21. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test).
    Hanson CE; Ruble GR; Essiet I; Hartman AB
    Comp Med; 2001 Jun; 51(3):224-9. PubMed ID: 11924776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic, antibiotic and phage receptor activity of proteins from Sh. boydii 15.
    Goldhar J; Eylan E; Barber C
    Zentralbl Bakteriol Orig A; 1975; 230(3):336-42. PubMed ID: 49990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a.
    Turbyfill KR; Kaminski RW; Oaks EV
    Vaccine; 2008 Mar; 26(10):1353-64. PubMed ID: 18276045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of lipopolysaccharide by strains of Shigella dysenteriae, Shigella flexneri and Shigella boydii and their cross-reacting strains of Escherichia coli.
    Chart H; Daniel RM; Cheasty T
    FEMS Microbiol Lett; 2009 Mar; 292(1):21-6. PubMed ID: 19222579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intergeneric antigenic relation of Hafnia and Shigella (S. flexneri and S. boydii) bacteria].
    Baturo AP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):19-21. PubMed ID: 2431565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The keratoconjunctivitis test].
    Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):7-27. PubMed ID: 4936246
    [No Abstract]   [Full Text] [Related]  

  • 29. Salmonella and shigella surveillance in Hungary, 1972-1976. II. Shigella surveillance.
    Rudnai O; Straub I; László VG; Hajnal A; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):53-65. PubMed ID: 7020354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and characteristics of the cytolysin A gene in Shigella strains and other members of the family Enterobacteriaceae.
    von Rhein C; Bauer S; Simon V; Ludwig A
    FEMS Microbiol Lett; 2008 Oct; 287(2):143-8. PubMed ID: 18754791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Keratoconjunctivitis producing pathogenicity of shigella with and without fimbriae in guinea pigs].
    Cefalù M; Puglisi C
    Riv Ist Sieroter Ital; 1967; 42(5):248-57. PubMed ID: 5601684
    [No Abstract]   [Full Text] [Related]  

  • 33. Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of shigella isolated from Andaman Islands, India.
    Roy S; Thanasekaran K; Dutta Roy AR; Sehgal SC
    Trop Med Int Health; 2006 Nov; 11(11):1694-8. PubMed ID: 17054749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the study of C-antigen in different strains of enterobacteria].
    Tallmeĭster ET; Tallmeĭster KhE
    Lab Delo; 1969; 5():309-11. PubMed ID: 4185268
    [No Abstract]   [Full Text] [Related]  

  • 35. [Correlation between biochemical features and pathogenicity of Shigella. IV. Threonine deaminase of Shigella strains producing and not producing keratoconjunctivitis in guinea pigs].
    Stypulkowska-Misiurewicz H; Noworyta J
    Med Dosw Mikrobiol; 1976; 28(2):131-6. PubMed ID: 775224
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunity to experimental keratoconjunctivitis shigellosa in guinea pigs.
    Ogawa H; Nakamura A; Nakaya R
    Jpn J Med Sci Biol; 1966 Aug; 19(4):209-14. PubMed ID: 5332601
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunochemistry of Shigella flexneri O-antigens: an analysis of the antigenic determinants of group factors.
    Freedlnder E; Manson R; Simmons DA
    Immunology; 1971 Jan; 20(1):11-6. PubMed ID: 4099504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic characteristics of colonies of Shigella flexneri 2a and 2b and their relation to antigenic composition, mouse virulence and immunogenicity.
    COOPER ML; KELLER HM; WALTERS EW
    J Immunol; 1957 Mar; 78(3):160-71. PubMed ID: 13429082
    [No Abstract]   [Full Text] [Related]  

  • 39. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on experimental keratoconjunctivitis shigellosa.
    Okamoto M
    Kitasato Arch Exp Med; 1980 Dec; 53(3-4):81-96. PubMed ID: 7035740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.